Both oxidative damage to cells and a decrease in antioxidant ability contribute to this disease
Heres what you need to know about when to get blood work done
In one study, adults who continued to take semaglutide at a maintenance dose did not gain weight, while those who switched to a placebo did
LSN3160440: a , L142A, b , Y145A, c , K202A, and d , L142A, Y145A, K202A
Cardiovascular risk reduction: As of October 2025, the 7 mg and 14 mg doses are FDA-approved to lower the risk of major adverse cardiovascular events such as heart attack or stroke in adults with type 2 diabetes who are at high cardiovascular risk
This can be done by, for example, hindering mitochondrial ETC and the activation of NOX, thus inhibiting ROS generation